Red Blood Cell Function in Nitric Oxide Biotransport
Red Blood Cell Function in Nitric Oxide Biotransport
批准号:
7456844
负责人:
MAHENDRA KAVDIA
金额:
$20.78万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-01 至 2011-05-31
关键词:
AreaBindingBioavailableBiochemicalBiological AvailabilityBioreactorsBlood SubstitutesBlood VesselsCell CommunicationCell membraneCell physiologyChronicConsumptionDataDevelopmentElectrodesEndotheliumErythrocytesEvaluationExperimental ModelsFunctional disorderGoalsHemoglobinHemolysisImmune responseKnowledgeLeadMeasuresMetabolismMethodsMicrocirculationNitratesNitric OxideNitritesOxygenPhysiologicalPhysiologyPlatelet Aggregation InhibitionPlayProductionPublic HealthPulmonary HypertensionPurposeRateReactionRegulationResearchResearch PersonnelRoleSeptic ShockSickle Cell AnemiaSimulateSiteSmooth MuscleSoluble Guanylate CyclaseSolutionsStudy modelsTestingTherapeuticaqueousbasedesignglycosylated-nitric oxide complex hemoglobin Ahemodynamicsin vivoneurotransmissionnitratenovel
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long-term goal is to quantify nitric oxide (NO) transport in the microcirculation in physiology and pathophysiology. In vascular wall, endothelium-derived nitric oxide reaches smooth muscle where it can activate soluble guanylate cyclase (sGC) and modulate vascular tone. The level of bioavailable NO are maintained by its production and consumption in the microcirculation. Despite intense research on the transport of NO from the production site (endothelium) to the target site (smooth muscle), question remains on whether and how significant amount of endothelium-derived NO reaches smooth muscle in the presence of efficient NO scavenger red blood cells (RBCs) in vascular lumen. The proposed research will provide functional relationship between hemodynamic and biochemical parameters in NO and RBC interaction. The Specific Aims for the proposed research are 1) to determine the role of oxygenation on NO interaction with RBC and 2) to quantify the differences in NO end-products formation from NO interaction with free Hb and RBC Hb. Based on the preliminary data, the hypotheses we will test are that (a) NO interaction with oxygenated RBCs will result in higher nitrite formation rate as compared to nitrite formation rate of NO interaction with deoxygenated RBCs, (b) oxygenated RBCs will have higher total NO concentration as compared to total NO concentration of deoxygenated RBCs, and (c) hemoglobin bound in the RBC membrane (RBC-hemoglobin) will results in higher total NO concentration and thus will have higher NO bioavailability as compared to that of free hemoglobin solution or RBC solution containing small amount of free Hb. For testing these hypotheses, we will use a novel bioreactor that simulates in vivo interactions of NO and RBCs. We will compare interaction products of NO with oxygenated- and deoxygenated- RBCs, presence of free hemoglobin with RBCs, and free hemoglobin. We will measure the reaction products of NO including intermediate products (s-nitrosohemoglobin & nitrosyl-Hb) and end-products (nitrite & nitrate) using chemiluminescence method. We will measure the gaseous and aqueous NO concentration using an NO electrode. We will additionally use UV/Vis spectrophotometric spectrum to quantify these concentration. By designing a new experimental model for studying biochemical interactions of NO and RBCs, we will advance the knowledge of biomedical researchers on these molecular interactions. This may lead to evaluation of therapeutics in areas as diverse as sickle cell anemia, pulmonary hypertension, septic shock, and blood substitutes. PUBLIC HEALTH RELEVANCE: Nitric oxide (NO) plays important roles in numerous physiological functions including regulation of vascular tone, neurotransmission, immune response and inhibition of platelet aggregation. The proposed research will significantly advance our fundamental understanding of NO metabolism in the microcirculation and provide biomedical researchers a new experimental model for studying biochemical interactions of NO and RBCs. The proposed research will also quantify the effect of free Hb on the NO metabolism. This knowledge is critical to the development of hemoglobin based oxygen carrier and the understanding the effects of chronic hemolysis in sickle cell disease and pulmonary hypertension.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.mvr.2009.10.002
发表时间:
2010-01
期刊:
Microvascular research
影响因子:
3.1
作者:
[Deonikar P, Kavdia M]
通讯作者:
Kavdia M
DOI:
10.1016/j.jtbi.2012.10.025
发表时间:
2013-01-21
期刊:
JOURNAL OF THEORETICAL BIOLOGY
影响因子:
2
作者:
[Deonikar, Prabhakar, Kavdia, Mahendra]
通讯作者:
Kavdia, Mahendra
DOI:
10.1016/j.mvr.2010.09.004
发表时间:
2010-12
期刊:
Microvascular research
影响因子:
3.1
作者:
[Deonikar P, Kavdia M]
通讯作者:
Kavdia M
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:8265529
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:7466966
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:8051607
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:7612754
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
Nitric Oxide-Superoxide Interactions in Endothelial Cell Dysfunction
-
批准号:7787434
-
项目类别:
-
资助金额:$9.49万
-
财政年份:2008
-
负责人:MAHENDRA KAVDIA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: